Author | Farhad Ravandi-Kashani, MD


Adding Nivolumab to Induction Chemotherapy Safe in Younger AML Patients

December 15, 2017

ByFarhad Ravandi-Kashani, MD

This video highlights a phase II trial that tested the addition of nivolumab to combination induction chemotherapy of cytarabine and idarubicin for patients with newly diagnosed acute myeloid leukemia.

Management of Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia

December 05, 2017

ByFarhad Ravandi-Kashani, MD

In this interview ahead of the ASH Annual Meeting we discuss the current management of Philadelphia chromosome–positive acute lymphoblastic leukemia and the role of stem cell transplantation.